{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:07:55Z","timestamp":1790813275523,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Microwave ablation (MWA) of lung tumors is a technique that is dependent on the ablationist\u2019s level of expertise. The selection of the optimum puncture path and determination of appropriate ablative parameters is the key to the success and safe of the procedure. The objective of this study was to describe the clinical use of a novel three-dimensional visualization ablation planning system (3D-VAPS) for aided MWA of stage I non-small cell lung cancer (NSCLC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was a single-arm, single-center, retrospective study. From May 2020 to July 2022, 113 consented patients with stage I NSCLC received MWA treatment in 120 MWA sessions. The 3D-VAPS was used to determine that (1) the overlap between the gross tumor region and simulated ablation; (2) the proper posture and appropriate puncture site on the surface of the body; (3) the puncture path; and (4) presetting preliminarily ablative parameters. Patients were monitored with contrast-enhanced CT scans at 1, 3, and 6 months, as well as every 6 months following that. The primary endpoints were technical success and a complete ablation rate. Local progression-free survival (LPFS), overall survival (OS), and comorbidities were secondary study objectives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The mean diameter of tumors was 1.9 \u00b1 0.4 cm (range 0.9-2.5 cm). The mean duration was 5.34 \u00b1 1.28 min (range 3.0\u201310.0 min). The mean power output was 42.58 \u00b1 4.23 (range 30.0-50.0W). The median follow-up time was 19.0 months (6.0-26.0 months). The technical success rate was 100%. Three-month after the procedure, the complete ablation rate was 97.35%. 6, 9, 12, and 24 months LPFS rates were 100%, 98.23%, 98.23%, and 96.46%, respectively. One-year and 2-year OS rates were 100% and 100%. There were no patients who died both during the procedure and after the MWA of 30 days. The complications after MWA included pneumothorax (38.33%), pleural effusion (26.67%), intrapulmonary hemorrhage (31.67%), and pulmonary infection (2.50%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This research describes and confirms that 3D-VAPS is a feasibility and safe method for MWA of stage I NSCLC treatment. 3D-VAPS may be helpful to optimize the puncture path, assess reasonable ablative parameters, and minimize complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_2093_22","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:37:41Z","timestamp":1675039061000},"page":"64-70","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["The safety and feasibility of three-dimensional visualization planning system for CT-guided microwave ablation of stage I NSCLC (diameter \u22642.5 cm): A pilot study"],"prefix":"10.4103","volume":"19","author":[{"given":"Yanting","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China"},{"name":"Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Engineering and Technology Research Center for Pediatric Drug Development, Shandong Medicine and Health Key Laboratory of Clinical Pharmacy, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pikun","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchao","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"254","DOI":"10.6004\/jnccn.2021.0013","article-title":"NCCN Guidelines Insights:Non-small cell lung cancer, Version 2.2021","volume":"19","author":"Ettinger","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"R2-20241021","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/ans.14861","article-title":"Outcomes following resection of non-small cell lung cancer in octogenarians","volume":"88","author":"Vazirani","year":"2018","journal-title":"ANZ J Surg"},{"key":"R3-20241021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cllc.2021.06.008","article-title":"Nomogram predicting overall survival benefit of stereotactic ablative radiotherapy for early-stage non-small cell lung cancer","volume":"23","author":"Jacobs","year":"2022","journal-title":"Clin Lung Cancer"},{"key":"R4-20241021","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1007\/s00330-022-08615-8","article-title":"Microwave ablation treatment for medically inoperable stage I non-small cell lung cancers:Long-term results","volume":"32","author":"Ni","year":"2022","journal-title":"Eur Radiol"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13244-021-00997-5","article-title":"Image-guided percutaneous ablation for the treatment of lung malignancies:Current state of the art","volume":"12","author":"P\u00e1ez-Carpio","year":"2021","journal-title":"Insights Imaging"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/ajco.13419","article-title":"Image-guided percutaneous microwave ablation of early-stage non-small cell lung cancer","volume":"16","author":"Ni","year":"2020","journal-title":"Asia Pac J Clin Oncol"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1007\/s00330-020-07634-7","article-title":"Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC):A systematic review and meta-analysis","volume":"31","author":"Chan","year":"2021","journal-title":"Eur Radiol"},{"key":"R8-20241021","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/j.wneu.2018.05.217","article-title":"Laser interstitial thermal therapy for posterior fossa lesions:An initial experience","volume":"117","author":"Borghei-Razavi","year":"2018","journal-title":"World Neurosurg"},{"key":"R9-20241021","first-page":"690","article-title":"[Curative effect analysis of ultrasound-guided percutaneous radiofrequency ablation for caudate lobe hepatocellular carcinoma]","volume":"29","author":"Zhou","year":"2021","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"R10-20241021","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4103\/jcrt.jcrt_1286_21","article-title":"Safety and efficacy of microwave ablation to treat pulmonary nodules under conscious analgosedation with sufentanil:A single-center clinical experience","volume":"18","author":"Cao","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"938827","DOI":"10.3389\/fonc.2022.938827","article-title":"Microwave ablation plus camrelizumab monotherapy or combination therapy in non-small cell lung cancer","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1148\/radiol.14132958","article-title":"Image-guided tumor ablation:Standardization of terminology and reporting criteria--a 10-year update","volume":"273","author":"Ahmed","year":"2014","journal-title":"Radiology"},{"key":"R13-20241021","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4103\/jcrt.jcrt_880_22","article-title":"Clinical practice guidelines on image-guided thermal ablation of primary and metastatic lung tumors (2022 edition)","volume":"18","author":"Ye","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"R14-20241021","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejrad.2009.12.009","article-title":"A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe:Results in ex vivo and in vivo porcine livers","volume":"79","author":"Yu","year":"2011","journal-title":"Eur J Radiol"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1080\/02656736.2018.1447149","article-title":"High power microwave ablation of normal swine lung:Impact of duration of energy delivery on adverse event and heat sink effects","volume":"34","author":"Kodama","year":"2018","journal-title":"Int J Hyperthermia"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1080\/02656736.2021.1961883","article-title":"Percutaneous lung and liver CT-guided ablation on swine model using microwave ablation to determine ablation size for clinical practice","volume":"38","author":"Habert","year":"2021","journal-title":"Int J Hyperthermia"},{"key":"R17-20241021","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/s21041370","article-title":"Combining augmented reality and 3D printing to improve surgical workflows in orthopedic oncology:smartphone application and clinical evaluation","volume":"21","author":"Moreta-Martinez","year":"2021","journal-title":"Sensors (Basel)"},{"key":"R18-20241021","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3390\/biomedicines10071569","article-title":"An analysis of microwave ablation parameters for treatment of liver tumors from the 3D-IRCADb-01 Database","volume":"10","author":"Radmilovi\u0107-Radjenovi\u0107","year":"2022","journal-title":"Biomedicines"},{"key":"R19-20241021","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.4103\/jcrt.JCRT_39_19","article-title":"Ultrasound-guided percutaneous microwave ablation assisted by a three-dimensional visualization preoperative treatment planning system for larger adrenal metastasis (D\u22654 cm):Preliminary results","volume":"15","author":"Wu","year":"2019","journal-title":"J Cancer Res Ther"},{"key":"R20-20241021","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/cncr.30531","article-title":"Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma","volume":"123","author":"Kutlu","year":"2017","journal-title":"Cancer"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/02656736.2019.1684575","article-title":"Efficacy and safety of CT-guided percutaneous thermal ablation for hepatocellular carcinoma adjacent to the second porta hepatis","volume":"36","author":"Xie","year":"2019","journal-title":"Int J Hyperth"},{"key":"R22-20241021","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/02656736.2016.1196395","article-title":"The vascular cooling effect in hepatic multipolar radiofrequency ablation leads to incomplete ablation ex vivo","volume":"32","author":"Poch","year":"2016","journal-title":"Int J Hyperth"},{"key":"R23-20241021","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jhbp.370","article-title":"Minimal vascular flows cause strong heat sink effects in hepatic radiofrequency ablation ex vivo","volume":"23","author":"Lehmann","year":"2016","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R24-20241021","doi-asserted-by":"crossref","first-page":"4182192","DOI":"10.1007\/s00330-020-06792-y","article-title":"Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment","volume":"30","author":"Cho","year":"2020","journal-title":"Eur Radiol"},{"key":"R25-20241021","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s00330-019-06411-5","article-title":"Clinical evaluation of in silico planning and real-time simulation of hepatic radiofrequency ablation (ClinicIMPPACT Trial)","volume":"30","author":"Moche","year":"2020","journal-title":"Eur Radiol"},{"key":"R26-20241021","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3389\/fonc.2020.00842","article-title":"Stereotactic image-guided microwave ablation for malignant liver tumors-A multivariable accuracy and efficacy analysis","volume":"10","author":"Tinguely","year":"2020","journal-title":"Front Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2093_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:42:57Z","timestamp":1787067777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2093_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2093_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,30]]},"assertion":[{"value":"2022-10-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}